Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AorTech, St Jude reaches milestone

This article was originally published in Clinica

Executive Summary

Biomaterials and medical device company AorTech International has received a milestone payment from its partnership with St Jude Medical. The payment - the result of a supply agreement established between the two companies in mid-2006 (see Clinica No 1201, p 18) - extends the exclusive use of AorTech's Elast-Eon 2 biomaterial in the field of cardiac pacing, ICD and cardiac monitoring leads, for an indefinite length of time. AorTech CEO Frank Maguire stated that the milestone payment formed part of the company's revenue expectations for 2008. The supply agreement also includes an extra optional milestone payment on the issue of new AorTech polymer intellectual property, which the company says would occur in the fourth quarter of 2009. According to Surrey, UK-based AorTech, its range of Elast-Eon polymers are widely accepted as being very biostable, making them suitable for long-term implantation.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT046495

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel